Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2019

01-01-2019 | Hemolytic Anemia | Review Article

Applications of Next Generation Sequencing in Haematological Disorders—Indian Status: Updates from ISHBT 2018

Authors: Madhavi Maddali, Poonkuzhali Balasubramanian

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 1/2019

Login to get access

Abstract

Research in India based on next generation sequencing (NGS) has been plentiful over the past few years. Significant progress in research both in benign and malignant haematology can be attributed to this technique. It has now progressed to both diagnostic and a theranostic modality in many areas of not only haematology but also other medical specialities. Papers presented at the annual conference of the Indian Society of Haematology and Blood Transfusion, ISHBT (Haematocon 2018) highlighted a snapshot of the research activities using NGS that are ongoing in various academic and other centres. This review summarizes the salient findings of the original research abstracts presented. The papers are divided into two broad subsections of non-malignant and malignant haematology.
Literature
1.
go back to reference Jamwal M, Aggarwal S, Sharma P, Bansal D, Malhotra P, Maitra A, Das R (2018) A next generation sequencing based approach to elucidate the clinical and genetic spectrum of uncommon congenital anemias. Indian J Hematol Blood Transfus 34(suppl 1):S5 Jamwal M, Aggarwal S, Sharma P, Bansal D, Malhotra P, Maitra A, Das R (2018) A next generation sequencing based approach to elucidate the clinical and genetic spectrum of uncommon congenital anemias. Indian J Hematol Blood Transfus 34(suppl 1):S5
2.
go back to reference More TA, Kedar P, Warang P, Dongerdiye R, Devendra R, Madkaikar M (2018) First report of dysfunctional mechanosensitive Piezo ion channel protein (PIEZO1) associated with hereditary xerocytosis in India. Indian J Hematol Blood Transfus 34(suppl 1):S23 More TA, Kedar P, Warang P, Dongerdiye R, Devendra R, Madkaikar M (2018) First report of dysfunctional mechanosensitive Piezo ion channel protein (PIEZO1) associated with hereditary xerocytosis in India. Indian J Hematol Blood Transfus 34(suppl 1):S23
3.
go back to reference Jajodia E, Fouzia NA, Abraham A, Korula A, Devasia AJ, Srivastava A, Mathews V, George B, Edison ES, Shaji RV (2018) Molecular diagnosis of RBC membranopathy and enzymopathy by long amplicon PCR based next-generation sequencing (LAP-NGS). Indian J Hematol Blood Transfus 34(suppl 1):S76 Jajodia E, Fouzia NA, Abraham A, Korula A, Devasia AJ, Srivastava A, Mathews V, George B, Edison ES, Shaji RV (2018) Molecular diagnosis of RBC membranopathy and enzymopathy by long amplicon PCR based next-generation sequencing (LAP-NGS). Indian J Hematol Blood Transfus 34(suppl 1):S76
4.
go back to reference Senthil Kumar G, Arun KA, Jajodia E, Jain N, George B, Srivastava A, Mathews V, Edison ES, Shaji RV (2018) A novel, NGS based method for the detection of haemoglobin variants. Indian J Hematol Blood Transfus 34(suppl 1):S113 Senthil Kumar G, Arun KA, Jajodia E, Jain N, George B, Srivastava A, Mathews V, Edison ES, Shaji RV (2018) A novel, NGS based method for the detection of haemoglobin variants. Indian J Hematol Blood Transfus 34(suppl 1):S113
5.
go back to reference Joshi G, Janet NB, Thenral SG, Sakthivel SM, Srivastava V, Srivastava A, Ramprasad VL, George B, Shaji RV (2018) Exome sequencing reveals complex genetic subtypes of Fanconi anaemia in Indian population. Indian J Hematol Blood Transfus 34(suppl 1):S29 Joshi G, Janet NB, Thenral SG, Sakthivel SM, Srivastava V, Srivastava A, Ramprasad VL, George B, Shaji RV (2018) Exome sequencing reveals complex genetic subtypes of Fanconi anaemia in Indian population. Indian J Hematol Blood Transfus 34(suppl 1):S29
6.
go back to reference Maddali M, Rajkumar SV, Sankari Devi G, Mathews V, George B, Srivastava A, Edison ES, Shaji RV (2018) A long amplicon PCR—next generation sequencing (LAP-NGS) method for efficient and cost-effective molecular diagnosis of haemophilia A and haemophilia B. Indian J Hematol Blood Transfus 34(suppl 1):S25 Maddali M, Rajkumar SV, Sankari Devi G, Mathews V, George B, Srivastava A, Edison ES, Shaji RV (2018) A long amplicon PCR—next generation sequencing (LAP-NGS) method for efficient and cost-effective molecular diagnosis of haemophilia A and haemophilia B. Indian J Hematol Blood Transfus 34(suppl 1):S25
7.
go back to reference Shanbhag S, Soni P, Deshpande R, Yadav S, Shetty S (2018) Unusual clinical and laboratory indicators in two cases leading to the diagnosis of Glanzmanns thrombasthenia (GT). Indian J Hematol Blood Transfus 34(suppl 1):S138 Shanbhag S, Soni P, Deshpande R, Yadav S, Shetty S (2018) Unusual clinical and laboratory indicators in two cases leading to the diagnosis of Glanzmanns thrombasthenia (GT). Indian J Hematol Blood Transfus 34(suppl 1):S138
8.
go back to reference Kawankar NK, Kulkarni B, Shetty S (2018) Identification of novel mutations in RASGRP2 gene in patients with unclassified platelet function disorder. Indian J Hematol Blood Transfus 34(suppl 1):S140 Kawankar NK, Kulkarni B, Shetty S (2018) Identification of novel mutations in RASGRP2 gene in patients with unclassified platelet function disorder. Indian J Hematol Blood Transfus 34(suppl 1):S140
9.
go back to reference Kamalanathan N, Arun KA, Korula A, Fouzia NA, Abraham A, George B, Mathews V, Edison ES (2018) Molecular diagnosis of primary immunodeficiency diseases. Indian J Hematol Blood Transfus 34(suppl 1):S159 Kamalanathan N, Arun KA, Korula A, Fouzia NA, Abraham A, George B, Mathews V, Edison ES (2018) Molecular diagnosis of primary immunodeficiency diseases. Indian J Hematol Blood Transfus 34(suppl 1):S159
10.
go back to reference Arun KA, Senthamizhselvi A, Suresh H, Edison ES, Korula A, Fouzia NA, George B, Shaji RV, Mathews V, Balasubramanian P (2018) Screening of genetic variants in congenital neutropenia by next generation sequencing. Indian J Hematol Blood Transfus 34(suppl 1):S31 Arun KA, Senthamizhselvi A, Suresh H, Edison ES, Korula A, Fouzia NA, George B, Shaji RV, Mathews V, Balasubramanian P (2018) Screening of genetic variants in congenital neutropenia by next generation sequencing. Indian J Hematol Blood Transfus 34(suppl 1):S31
11.
go back to reference Bhanshe P, Patkar N, Kodgule R, Jain H, Bagal N, Sangar M, Khattry N, Subramanian PG, Gujral D, Ghoghale S (2018) Ultradeep next generation sequencing (NGS) based measurable residual disease (MRD) assessment in NPM1 mutated acute myeloid leukemia (AML) is the most important predictor of outcome. Indian J Hematol Blood Transfus 34(suppl 1):S14 Bhanshe P, Patkar N, Kodgule R, Jain H, Bagal N, Sangar M, Khattry N, Subramanian PG, Gujral D, Ghoghale S (2018) Ultradeep next generation sequencing (NGS) based measurable residual disease (MRD) assessment in NPM1 mutated acute myeloid leukemia (AML) is the most important predictor of outcome. Indian J Hematol Blood Transfus 34(suppl 1):S14
12.
go back to reference Naeem F, Raval G, Kodgule R, Chaudhary S, Joshi S, Patkar N (2018) Ultradeep error corrected next generation sequencing (NGS) of CEBPA mutations in acute myeloid leukemia. Indian J Hematol Blood Transfus 34(suppl 1):S261 Naeem F, Raval G, Kodgule R, Chaudhary S, Joshi S, Patkar N (2018) Ultradeep error corrected next generation sequencing (NGS) of CEBPA mutations in acute myeloid leukemia. Indian J Hematol Blood Transfus 34(suppl 1):S261
13.
go back to reference Ghai SR, Raval G, Kodgule R, Bhanshe P, Choudhary S, Joshi S, Tembhare P, Gujral S, Subramanian PG, Patkar N (2018) NUP98-NSD1 gene rearrangement in acute myeloid leukemia (AML)—report of two cases detected by targeted RNA sequencing. Indian J Hematol Blood Transfus 34(suppl 1):S15 Ghai SR, Raval G, Kodgule R, Bhanshe P, Choudhary S, Joshi S, Tembhare P, Gujral S, Subramanian PG, Patkar N (2018) NUP98-NSD1 gene rearrangement in acute myeloid leukemia (AML)—report of two cases detected by targeted RNA sequencing. Indian J Hematol Blood Transfus 34(suppl 1):S15
14.
go back to reference Shaikh AF, Raval G, Kodgule R, Choudhary S, Joshi S, Bhanshe P, Tembhare P, Subramanian PG, Gujral S, Patkar N (2018) A laboratory developed targeted RNA sequencing assay for identification of fusion genes in BCR-ABL1 like precursor B-lineage acute lymphoblastic leukemia (BCR-ABL1 like BCP-ALL). Indian J Hematol Blood Transfus 34(suppl 1):S16 Shaikh AF, Raval G, Kodgule R, Choudhary S, Joshi S, Bhanshe P, Tembhare P, Subramanian PG, Gujral S, Patkar N (2018) A laboratory developed targeted RNA sequencing assay for identification of fusion genes in BCR-ABL1 like precursor B-lineage acute lymphoblastic leukemia (BCR-ABL1 like BCP-ALL). Indian J Hematol Blood Transfus 34(suppl 1):S16
15.
go back to reference Soni VR, Raval G, Kodgule R, Chaudhary S, Joshi S, Bhanshe P, Subramanium PG, Tembhare P, Gujral D, Patkar N (2018) Development of an in-house low cost RNA sequencing panel for detection of myeloid neoplasms with clonal eosinophilia. Indian J Hematol Blood Transfus 34(suppl 1):S327 Soni VR, Raval G, Kodgule R, Chaudhary S, Joshi S, Bhanshe P, Subramanium PG, Tembhare P, Gujral D, Patkar N (2018) Development of an in-house low cost RNA sequencing panel for detection of myeloid neoplasms with clonal eosinophilia. Indian J Hematol Blood Transfus 34(suppl 1):S327
16.
go back to reference Chopra A, Verma D, Singh J, Bakhshi S, Seth R, Kumar R (2018) Comprehensive analysis of lncRNAome in immature T-ALL. Indian J Hematol Blood Transfus 34(suppl 1):S243 Chopra A, Verma D, Singh J, Bakhshi S, Seth R, Kumar R (2018) Comprehensive analysis of lncRNAome in immature T-ALL. Indian J Hematol Blood Transfus 34(suppl 1):S243
17.
go back to reference Benjamin ESB, Bharathi MR, Senthamizhselvi A, Abraham A, George B, Srivastava A, Mathews V, Balasubramanian P (2018) BCR-ABL kinase domain mutation analysis by next generation sequencing detected additional mutations in chronic myeloid leukemia patients with suboptimal response to imatinib. Indian J Hematol Blood Transfus 34(suppl 1):S39 Benjamin ESB, Bharathi MR, Senthamizhselvi A, Abraham A, George B, Srivastava A, Mathews V, Balasubramanian P (2018) BCR-ABL kinase domain mutation analysis by next generation sequencing detected additional mutations in chronic myeloid leukemia patients with suboptimal response to imatinib. Indian J Hematol Blood Transfus 34(suppl 1):S39
18.
go back to reference Tripthi B, Mehta A, Chaudhary S, Joshi S, Raval G, Kodgule R, Gujral S, Subramanian PG, Tembhare P, Patkar N (2018) Ultra deep error corrected next generation sequencing (NGS) of ABL1 kinase domain mutation (KDM) in BCR-ABL1 positive malignancies. Indian J Hematol Blood Transfus 34(Suppl 1):S301 Tripthi B, Mehta A, Chaudhary S, Joshi S, Raval G, Kodgule R, Gujral S, Subramanian PG, Tembhare P, Patkar N (2018) Ultra deep error corrected next generation sequencing (NGS) of ABL1 kinase domain mutation (KDM) in BCR-ABL1 positive malignancies. Indian J Hematol Blood Transfus 34(Suppl 1):S301
19.
go back to reference Maddali M, Suresh H, Kulkarni UP, Devasia AJ, Fouzia NA, Korula A, Abraham A, George B, Srivastava A, Shaji RV, Mathews V, Balasubramanian P (2018) Molecular characterization of triple negative myeloproliferative neoplasms (TN-MPN) by targeted next generation sequencing. Indian J Hematol Blood Transfus 34(Suppl 1):S332 Maddali M, Suresh H, Kulkarni UP, Devasia AJ, Fouzia NA, Korula A, Abraham A, George B, Srivastava A, Shaji RV, Mathews V, Balasubramanian P (2018) Molecular characterization of triple negative myeloproliferative neoplasms (TN-MPN) by targeted next generation sequencing. Indian J Hematol Blood Transfus 34(Suppl 1):S332
Metadata
Title
Applications of Next Generation Sequencing in Haematological Disorders—Indian Status: Updates from ISHBT 2018
Authors
Madhavi Maddali
Poonkuzhali Balasubramanian
Publication date
01-01-2019
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2019
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-01068-4

Other articles of this Issue 1/2019

Indian Journal of Hematology and Blood Transfusion 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine